![]() |
Volumn 26, Issue 5, 2003, Pages
|
Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANDROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
GONADORELIN;
PROSTATE SPECIFIC ANTIGEN;
AGED;
ARTICLE;
BLOOD;
DISEASE COURSE;
DRUG POTENTIATION;
HUMAN;
MALE;
MIDDLE AGED;
NEOPLASM;
PATHOLOGY;
PROSTATE TUMOR;
QUALITY OF LIFE;
TREATMENT OUTCOME;
AGED;
AGED, 80 AND OVER;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
DISEASE PROGRESSION;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS, HORMONE-DEPENDENT;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 1542673411
PISSN: None
EISSN: 1537453X
Source Type: Journal
DOI: 10.1097/01.coc.0000091351.09243.15 Document Type: Article |
Times cited : (22)
|
References (0)
|